Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
NRX Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.05
12.07.21
€15.00
12.07.22
86.43%
23.07.21

Capable Management
Could be worthwhile Investment >10% per year
Innovative
Few uniques
buy
GW Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€80.50
24.03.20
€180.00
04.11.21
127.33%
24.06.21

buy
Evotec SE

Start price
Target price
Perf. (%)
€23.43
23.09.20
€36.00
04.11.21
58.26%
21.06.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
buy
BMW AG VZO

Start price
Target price
Perf. (%)
€55.05
19.12.20
€69.00
19.06.21
34.79%
19.06.21

High dividend yield expected
Revenue decline/stagnation expected
Below average Management
Little innovation
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€58.19
30.08.20
€80.00
04.11.21
182.66%
17.06.21

Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€20.27
06.01.21
€20.00
26.11.21
-26.32%
08.06.21

Probably not worthwhile Investment
overvalued
Risky balance sheet
Increased challenges to pay loans and raise capital
buy
Sixt SE VZO

Start price
Target price
Perf. (%)
€47.75
01.09.20
€72.00
04.11.21
53.09%
08.06.21

Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€33.90
09.02.21
€20.00
09.02.23
-69.44%
11.05.21

Risky Investment
buy
Varta AG

Start price
Target price
Perf. (%)
€81.20
28.01.20
€100.00
04.11.21
40.09%
07.05.21

Could be very worthwhile Investment >20% year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€90.00
09.11.20
€180.00
09.11.21
103.67%
04.05.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very Future proof/growth oriented business model
Capable Management
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€13.38
08.03.21
€15.00
13.62%
10.03.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Hamburger Hafen und Logistik AG

Start price
Target price
Perf. (%)
€18.56
09.02.21
€21.00
15.30%
09.03.21

Top 10 in its market
High risks for its business
Probably not worthwhile Investment
Revenue decline/stagnation expected
buy
Tilray Inc

Start price
Target price
Perf. (%)
€16.25
15.01.21
€35.00
15.01.22
194.68%
10.02.21

Could be worthwhile Investment >10% per year
buy
Varta AG

Start price
Target price
Perf. (%)
€136.10
01.02.21
€145.00
10.95%
05.02.21

Very positive Cash Flow expected
High Investments for future growth
Some uniques
Undervalued
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€128.76
27.01.21
€110.00
27.01.22
1.85%
03.02.21

Well known brand
Risky Investment
buy
Varta AG

Start price
Target price
Perf. (%)
€129.90
25.01.21
€140.00
14.40%
26.01.21

Very positive Cash Flow expected
High Investments for future growth
Some uniques
Undervalued
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€191.40
21.01.21
€200.00
4.49%
26.01.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€162.60
16.10.20
€175.00
04.11.21
8.86%
20.01.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
WD-40 Company

Start price
Target price
Perf. (%)
€240.00
07.01.21
€250.00
3.33%
08.01.21

Market Leader or Top 3
Very small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
buy
Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€17.10
26.11.20
€20.00
26.11.21
18.54%
06.01.21

Probably not worthwhile Investment
overvalued
Risky balance sheet
Increased challenges to pay loans and raise capital
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€59.67
04.10.20
€125.00
04.11.21
149.51%
01.12.20

Capable Management
Medium risks for its business
Small cyclical dependencies
Could be very worthwhile Investment >20% year
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.20
07.11.20
€6.40
23.49%
30.11.20

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
buy
Varta AG

Start price
Target price
Perf. (%)
€116.50
14.08.20
€115.00
04.11.21
-0.43%
06.11.20

Future proof or reliable business model
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€126.00
06.09.20
€155.00
04.11.21
28.41%
05.11.20

Medium risks for its business
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€57.26
14.09.20
€78.00
16.10.20
39.19%
16.10.20

Could be very worthwhile Investment >20% year